Observational studyPloS one2017

Effectiveness of dasabuvir/ombitasvir/paritaprevir/ritonavir for hepatitis C virus in clinical practice: A population-based observational study.

Maya Leventer-Roberts et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.